As of November 2024 Protalix BioTherapeutics has a market cap of โน10.20 Billion. This makes Protalix BioTherapeutics the world's 8587th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 20th, 2024 the market cap of Protalix BioTherapeutics was reported to be: